Autoimmune pancreatitis mimicking malignant pancreatic tumor in 79-year-old patient – a case report

Authors

  • Mariusz Partyka Department of Gastroenterology and Hepatology, Teaching Hospital No 1 in Rzeszow; Nursing and Health Science Institute, Medical Department, University od Rzeszow
  • Mariusz Jednakiewicz Department of Anesthesiology and Intensive Care, Teaching Hospital No 1 in Rzeszow
  • Robert Staroń Department of Gastroenterology and Hepatology, Teaching Hospital No 1 in Rzeszow
  • Dorota Gutkowska Nursing and Health Science Institute, Medical Department, University od Rzeszow
  • Krzysztof Gutkowski Department of Gastroenterology and Hepatology, Teaching Hospital No 1 in Rzeszow; Physiotherapy Institute, Medical Department, University of Rzeszow

DOI:

https://doi.org/10.15584/medrev.2016.3.7

Keywords:

autoimmune pancreatitis, pancreatic tumor, IgG4

Abstract

Autoimmune pancreatitis, (AIP) is a rare inflammatory disease of this organ distinguished by a specific clinical course and a good response to glucocorticosteroids. The disease may be limited to the pancreas itself or be part of a multi-organ autoimmune inflammatory process. The basis of diagnosis are radiological image techniques, enabling the location of organ changes, and endoscopic ultrasound examination, giving the possibility of material collection for cytological examination, supplemented by determination of the concentration of G4 subclass immunoglobulins. We report a case of autoimmune pancreatitis mimicking malignant tumor of this organ in a 79- year-old male patient.

Downloads

Download data is not yet available.

References

Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006;6 (4):23.

Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40 (3):352–358.

Kamisawa T, Kim MH, Liao WC, et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas 2011;40 (2):200–205.

Wu L, Li W, Huang X, Wang Z. Clinical features and comprehensive diagnosis of autoimmune pancreatitis in China. Digestion 2013;88:128–134.

Kamisawa T, Chari ST, Giday SA, et al. Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey.

Pancreas 2011;40 (6):809–814.

Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139 (1):140–148.

Kanno A, Nishimori I, Masamune A, at al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 2012;41(6):835-839.

Smith CD, Behrns KE, van Heerden JA, Sarr MG. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 1994;81(4):585-589.

Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4 (8):1010–1016.

Mizuno N, Bhatia V, Hosoda W, at al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009;44(7):742-750.

Matsubayashi H, Kakushima N, Takizawa K, Tanaka M, Imai K, Hotta K, Ono H. Diagnosis of autoimmune pancreatitis. World J Gastroenterol 2014;20 (44):16559-16569.

Chari ST, Kloeppel G, Zhang L, at al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010;39(5):549–554.

Sugumar A, Kloppel G, Chari ST. Autoimmune pancreatitis: pathologic subtypes and their implications for its diagnosis. Am J Gastroenterol 2009;104(9):2308–2310.

Zhang L, Chari S, Smyrk TC, et al. Autoimmune pancreatitis (AIP) type 1 and type 2:an international consensus study on histopathologic diagnostic criteria. Pancreas 2011;40 (8):1172–1179.

Oseini AM, Chaiteerakij R, Shire AM, at al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011;54(3):940-948.

Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102 (8):1646–1653.

Kawa S, Hamano H, Umemura T, Kiyosawa K, Uehara T. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res 2007;37 (3):487-495.

Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539–551.

Ardila-Suarez O, Abril A, Gómez-Puerta JA. IgG4-related disease: A concise review of the current literature. Reumatol Clin 2016 pii:S1699-258X(16)30053-5.

Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62 (12):1771-1776.

Kamisawa T, Okazaki K, Kawa S, at al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45 (5):471–477.

Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009;58 (11):1504-1507.

Hart PA, Topazian MD, Witzig TE, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62 (11):1607-1615.

Kamisawa T, Chari ST, Lerch MM, et al. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut 2013;62(9):1373-80.

Chintanaboina J, Yang Z, Mathew A. Autoimmune Pancreatitis: A Diagnostic Challenge for the Clinician. South Med J 2015;108 (9):579-589.

Downloads

Published

2016-10-01

How to Cite

Partyka, M., Jednakiewicz, M., Staroń, R., Gutkowska, D., & Gutkowski, K. (2016). Autoimmune pancreatitis mimicking malignant pancreatic tumor in 79-year-old patient – a case report. European Journal of Clinical and Experimental Medicine, 14(3), 324–330. https://doi.org/10.15584/medrev.2016.3.7

Issue

Vol. 14 No. 3 (2016): Medical Review

Section

CASUISTIC PAPERS

License

Copyright (c) 2016 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.